https://www.ema.europa.eu/medicines/human/EPAR/OptiMARK 2012 United Kingdom French English syndication feed organometallic compounds contrast media organometallic compounds drug approval drug labeling injections, intravenous magnetic resonance imaging central nervous system diseases liver diseases drug interactions pregnancy breast feeding gadoversetamide gadoversetamide gadoversetamide organometallic compounds package leaflet summary of product characteristics drug evaluation liver diseases central nervous system diseases
--- https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2010/14084a-fra.php https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2010/14618a-fra.php 2010 Canada English French COVID-19 renal insufficiency gadoversetamide gadoversetamide gadoversetamide organometallic compounds organometallic compounds contrast media contrast media nephrogenic fibrosing dermopathy organometallic compounds popular works pharmacovigilance note Contraindications, Drug